Biotech reported positive interim data from a mid-stage trial of a treatment for the rare muscle disorder Duchenne muscular ...

Wave Life Sciences Ltd. (NASDAQ:WVE) revealed interim data from the ongoing Phase 2 FORWARD-53 study of WVE-N531 for Duchenne ...

Projects focus on cancer therapies, robotic clot removal catheters, and mRNA vaccines, among other technologies ...

Who should decide whether scientists are allowed to modify viruses to make them more infectious and deadly to humans? The ...

Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a global leader in supply chain solutions for the life sciences industry, and SK ...

Shares of Wave Life Sciences WVE surged 53.4% on Tuesday after the company announced positive interim data from a mid-stage ...

Shares in Wave rose 53% after the trial data was announced, taking its market cap above the $1 billion threshold. The company ...

“The new dedicated life sciences organization represents a significant advancement in how we approach health security. It will enhance our ability to support a swift response to health emergencies, ...

Report by Hays compares talent pools in 30 economies across five sectors, such as technology, engineering, manufacturing and ...

Carrier announces new CEIV Pharma certified U.S stations, underscores commitment to quality in life sciences handling.

Work has begun on a 23-storey life sciences tower in Canary Wharf. Developers Canary Wharf Group and Dutch investor Kadans ...

A heart surgeon who performed a revolutionary aortic valve replacement therapy on patients with heart valve failure undergoes ...